Bogle Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Bogle Investment Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,066	Closed	-$358K	–	343
2019 Q3	$358K	Buy	+21,066	New	+$383K	0.03%	248
2019 Q1	–	Sell	-88,102	Closed	-$2.48M	–	419
2018 Q4	$2.48M	Buy	+88,102	New	+$2.58M	0.19%	138
2018 Q3	–	Sell	-88,323	Closed	-$3.31M	–	361
2018 Q2	$3.31M	Buy	88,323 +12,158	+16%	+$477K	0.24%	120
2018 Q1	$2.99M	Sell	76,165 -92,541	-55%	-$3.38M	0.23%	121
2017 Q4	$5.47M	Sell	168,706 -55,776	-25%	-$1.67M	0.4%	90
2017 Q3	$6.99M	Sell	224,482 -29,866	-12%	-$884K	0.48%	83
2017 Q2	$7.11M	Buy	+254,348	New	+$5.76M	0.52%	83

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bogle Investment Management's XENT Position: Q4 2019 in Review

Bogle Investment Management sold out of Intersect ENT, Inc (XENT) in Q4 2019, closing a stake of 21,066 shares — an estimated $358K sold.

Bogle Investment Management first reported a position in XENT in Q2 2017 and held it in 7 quarters. The position peaked at $7.11M in Q2 2017. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

Bogle Investment Management reported no remaining Intersect ENT, Inc position as of Q4 2019 after selling out during the quarter.
Bogle Investment Management sold 21,066 Intersect ENT, Inc shares in Q4 2019, an estimated $358K.
Bogle Investment Management first reported a position in Intersect ENT, Inc in Q2 2017 and held it in 7 quarters.
Bogle Investment Management's Intersect ENT, Inc position peaked at $7.11M in Q2 2017.
120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Bogle Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.